Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 35

Sort by

Sort Order Select

Journal Articles

Fludarabine, cyclophosphamide, and melphalan (FCM) preconditioning in haploidentical hematopoietic stem cell transplantation for severe aplastic anemia: Update of a prospective, multicenter, single-arm clinical study

Xiaoping Li, Yali Zhou, Bo Nie, Peng Zhao, Jiong Hu, Chun Wang, Hao Zhang, Xiaolin Yin, Wang Sanbin

Blood (2025) 146 (Supplement 1): 4201.

https://doi.org/10.1182/blood-2025-4201

Published: 2025

Journal Articles

Comparative study of hetrombopag vs. eltrombopag in promoting platelet engraftment post-autologous hematopoietic stem cell transplantation: A multicenter clinical trial

Yimei Feng, Pan Zhao, Mingqiang Ren, Liangliang Ma, Peng Zhao, Hanqing Zeng, Linhui Wang, Mingxia Shi, Hongyun Xing, Hai Yi, Tao Lang, Xi Zhang

Blood (2025) 146 (Supplement 1): 7743.

https://doi.org/10.1182/blood-2025-7743

Published: 2025

Journal Articles

All-trans retinoic acid mitigates IL-1β-driven NEU1-mediated megakaryocyte desialylation and dysfunction in immune thrombocytopenia

Peng Zhao, Jing-Li Han, Hai-Xia Fu, Zhuo-Yu An, Yue Jin, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 1243.

https://doi.org/10.1182/blood-2025-1243

Published: 2025

Journal Articles

Iguratimod plus low-dose rituximab as second-line treatment in adults with primary immune thrombocytopenia: A multicenter, open-label, randomized, controlled, Phase 2 trial

Qiu-Sha Huang, Zhuo-Yu An, Peng Zhao, Qi Chen, Jin Wu, Hai-Xia Fu, Yujun Dong, Hongmei Jing, Liping Dou, Hui Liu, Yi Liu, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3044.

https://doi.org/10.1182/blood-2025-3044

Published: 2025

Journal Articles

The selective JAK1 inhibitor upadacitinib restores impaired neutrophil chemotaxis in the proplatelet formation of immune thrombocytopenia

Qiu-Sha Huang, Qing-Yuan Qu, Zhuo-Yu An, Peng Zhao, Qi Chen, Jin Wu, Hai-Xia Fu, Ying-Jun Chang, Xiang-Yu Zhao, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 197.

https://doi.org/10.1182/blood-2025-197

Published: 2025

Journal Articles

Efficacy and safety profile of inaticabtagene autoleucel in Chinese patients with Philadelphia chromosome-positive b-ALL: Insights from real-world data

Blood (2025) 146 (Supplement 1): 6855.

https://doi.org/10.1182/blood-2025-6855

Published: 2025

Journal Articles

Single-cell dissection of pathogenic T-cell response to tacrolimus in immune thrombocytopenia

Li-Ping Yang, Peng Zhao, Qiu-Sha Huang, Xiang-Yu Zhao, Qian Jiang, Ying-Jun Chang, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3024.

https://doi.org/10.1182/blood-2025-3024

Published: 2025

Journal Articles

Stratos: An AI-driven biomarker signature for prognostic risk stratification in transplant-associated thrombotic microangiopathy - a nationwide, multicenter study

Blood (2025) 146 (Supplement 1): 120.

https://doi.org/10.1182/blood-2025-120

Published: 2025

Journal Articles

Novel insights from the largest cohort to date: Elucidating risk factors, clinical outcomes, and prognostic predictors in autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation

Liqian Zhang, Zhuo-Yu An, Peng Zhao, Hai-Xia Fu, Yuanyuan Zhang, Xiao-Dong Mo, Fengrong Wang, Yuqian Sun, Meng Lv, Xiangyu Zhao, YuHong Chen, Yu Wang, Ying-Jun Chang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 6046.

https://doi.org/10.1182/blood-2025-6046

Published: 2025

Journal Articles

Thrombotic thrombocytopenic purpura after allogeneic hematopoietic cell transplantation: A rare but fatal complication.

Blood (2025) 146 (Supplement 1): 6045.

https://doi.org/10.1182/blood-2025-6045

Published: 2025

Journal Articles

Management and outcomes of acute coronary syndromes in patients with immune thrombocytopenia: A single-center real-world study

Jin Wu, Liqin Cao, Qiu-Sha Huang, Zhuo-Yu An, Peng Zhao, Hai-Xia Fu, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 4822.

https://doi.org/10.1182/blood-2025-4822

Published: 2025

Journal Articles

The JAK1/2 inhibitor baricitinib revealed unique immune biomarkers in multirefractory immune thrombocytopenia patients

Zhuo-Yu An, Peng Zhao, Hai-Xia Fu, Xiaolu Zhu, Yun He, Qiu-Sha Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 4820.

https://doi.org/10.1182/blood-2025-4820

Published: 2025

Journal Articles

Baricitinib reveals LGALS3BP as a novel pathogenic factor and therapeutic target in immune thrombocytopenia

Kexin Shen, Jingli Han, Zhuo-Yu An, Peng Zhao, Hai-Xia Fu, Qiu-Sha Huang, Jin Wu, Li-Ping Yang, Yuanyuan Zhang, Ying-jun Chang, Xiangyu Zhao, Yu Wang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 846.

https://doi.org/10.1182/blood-2025-846

Published: 2025

Journal Articles

Outcome and recovery trajectories for intracerebral hemorrhage in adults with primary immune thrombocytopenia

Peng Zhao, Ming Hou, Yi Liu, Ru Feng, Yujun Dong, Hai-Xia Fu, Qiu-Sha Huang, Jin Wu, Zhuoyu An, Yuanyuan Zhang, Xiangyu Zhao, Ying-jun Chang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 3033.

https://doi.org/10.1182/blood-2025-3033

Published: 2025

Journal Articles

Development and prospective validation of a prognostic model for diffuse alveolar hemorrhage after allogeneic hematopoietic stem cell transplantation

Qiu-Sha Huang, Zhuo-Yu An, Peng Zhao, Xiaolu Zhu, Yun He, Hai-Xia Fu, Fengrong Wang, Yuanyuan Zhang, Xiao-Dong Mo, Wei Han, Chen-hua Yan, Ting-ting Han, Yao Chen, Yu Wang, Ying-Jun Chang, Xiang-Yu Zhao, Lanping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 4276.

https://doi.org/10.1182/blood-2025-4276

Published: 2025

Journal Articles

Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: Lessons learned from a national representative study

Peng Zhao, Zhixue Li, Erlie Jiang, Shengjin Fan, Pengcheng He, Jingzhi Wang, Linghui Xia, Qiu-Sha Huang, Jin Wu, Zhuoyu An, Hai-Xia Fu, Yuanyuan Zhang, Xiangyu Zhao, Yu Wang, Lan-Ping Xu, Xiaojun Huang, Xiaohui Zhang

Blood (2025) 146 (Supplement 1): 4263.

https://doi.org/10.1182/blood-2025-4263

Published: 2025

Journal Articles

Efficacy and safety profile of inaticabtagene autoleucel in Chinese patients with B-cell acute lymphoblastic leukemia: Insights from real-world data

Blood (2025) 146 (Supplement 1): 5122.

https://doi.org/10.1182/blood-2025-5122

Published: 2025

Journal Articles

Long-term treatment continuation of gecacitinib in myelofibrosis patients after ruxolitinib failure

Blood (2025) 146 (Supplement 1): 5584.

https://doi.org/10.1182/blood-2025-5584

Published: 2025

Journal Articles

Genetic Associations and Platelet Count Trajectories in Gestational Thrombocytopenia and Immune Thrombocytopenia during Pregnancy

Kexin Shen, Chen Zhao, Lulu Wang, Mengtong Zang, Peng Zhao, Zhuo-Yu An, Xiaolu Zhu, Qiusha Huang, HaiXia Fu, Xiaojun Huang, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 2566.

https://doi.org/10.1182/blood-2024-205459

Published: 2024

Journal Articles

Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs

Guo-Ling Wang, Ting Wang, Jing-Li Han, Li-Xin Wu, Xuan-Zhong Chen, Zhuo-Yu An, Chen-Cong Wang, Peng Zhao, Lu-Lu Wang, Meng-Tong Zang, Wei Zheng, Hai-Xia Fu, Jia Feng, Hong-Yu Zhang, Xiaohui Zhang

Blood (2024) 144 (Supplement 1): 2041.

https://doi.org/10.1182/blood-2024-208043

Published: 2024

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Fludarabine, cyclophosphamide, and melphalan (FCM) preconditioning in haploidentical hematopoietic stem cell transplantation for severe aplastic anemia: Update of a prospective, multicenter, single-arm clinical study

Comparative study of hetrombopag vs. eltrombopag in promoting platelet engraftment post-autologous hematopoietic stem cell transplantation: A multicenter clinical trial

All-trans retinoic acid mitigates IL-1β-driven NEU1-mediated megakaryocyte desialylation and dysfunction in immune thrombocytopenia

Iguratimod plus low-dose rituximab as second-line treatment in adults with primary immune thrombocytopenia: A multicenter, open-label, randomized, controlled, Phase 2 trial

The selective JAK1 inhibitor upadacitinib restores impaired neutrophil chemotaxis in the proplatelet formation of immune thrombocytopenia

Efficacy and safety profile of inaticabtagene autoleucel in Chinese patients with Philadelphia chromosome-positive b-ALL: Insights from real-world data

Single-cell dissection of pathogenic T-cell response to tacrolimus in immune thrombocytopenia

Stratos: An AI-driven biomarker signature for prognostic risk stratification in transplant-associated thrombotic microangiopathy - a nationwide, multicenter study

Novel insights from the largest cohort to date: Elucidating risk factors, clinical outcomes, and prognostic predictors in autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation

Thrombotic thrombocytopenic purpura after allogeneic hematopoietic cell transplantation: A rare but fatal complication.

Management and outcomes of acute coronary syndromes in patients with immune thrombocytopenia: A single-center real-world study

The JAK1/2 inhibitor baricitinib revealed unique immune biomarkers in multirefractory immune thrombocytopenia patients

Baricitinib reveals LGALS3BP as a novel pathogenic factor and therapeutic target in immune thrombocytopenia

Outcome and recovery trajectories for intracerebral hemorrhage in adults with primary immune thrombocytopenia

Development and prospective validation of a prognostic model for diffuse alveolar hemorrhage after allogeneic hematopoietic stem cell transplantation

Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: Lessons learned from a national representative study

Efficacy and safety profile of inaticabtagene autoleucel in Chinese patients with B-cell acute lymphoblastic leukemia: Insights from real-world data

Long-term treatment continuation of gecacitinib in myelofibrosis patients after ruxolitinib failure

Genetic Associations and Platelet Count Trajectories in Gestational Thrombocytopenia and Immune Thrombocytopenia during Pregnancy

Tandem CAR-T-Cell Therapy Targeting CD5 and CD7: Facilitating Condition-Free Engraftment of Epitope-Edited Allogeneic HSCs

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only